Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dioxamycin, a new benz[a]anthraquinone antibiotic.

R Sawa1, N Matsuda, T Uchida

  • 1Institute of Microbial Chemistry, Tokyo, Japan.

The Journal of Antibiotics
|April 1, 1991
PubMed
Summary

A novel antibiotic, dioxamycin, was isolated from Streptomyces xantholiticus. This compound shows in vitro activity against Gram-positive bacteria and certain tumor cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decontamination of outdoor school swimming pools in Fukushima after the nuclear accident in March 2011.

Health physics·2013
Same author

Tyropeptins A and B, new proteasome inhibitors produced by Kitasatospora sp. MK993-dF2. II. Structure determination and synthesis.

The Journal of antibiotics·2002
Same author

Migrastatin, a novel 14-membered ring macrolide, inhibits anchorage-independent growth of human small cell lung carcinoma Ms-1 cells.

The Journal of antibiotics·2002
Same author

Isolation and structural determination of phepropeptins A, B, C, and D, new proteasome inhibitors, produced by Streptomyces sp.

The Journal of antibiotics·2002
Same author

Sulphostin, a potent inhibitor for dipeptidyl peptidase IV from Streptomyces sp. MK251-43F3.

The Journal of antibiotics·2001
Same author

Biosynthesis of IC202C, a new siderophore with immunosuppressive activity.

The Journal of antibiotics·2001

Area of Science:

  • Microbiology
  • Natural Product Chemistry
  • Pharmacology

Background:

  • Streptomyces species are a prolific source of bioactive natural products, including antibiotics.
  • Benz[a]anthraquinone antibiotics, such as capoamycin, exhibit significant biological activities.
  • The discovery of new antibiotics is crucial for combating antimicrobial resistance.

Purpose of the Study:

  • To isolate and characterize a novel antibiotic from a Streptomyces strain.
  • To elucidate the chemical structure of the new antibiotic.
  • To evaluate the in vitro biological activity of the isolated compound.

Main Methods:

  • Isolation of the antibiotic from the culture broth of Streptomyces strain MH406-SF1.
  • Purification using countercurrent chromatography, column chromatography, and preparative HPLC.

Related Experiment Videos

  • Structure elucidation employing HRFAB-MS and various 2D NMR techniques (1H-1H COSY, 13C-1H COSY, HMBC, NOESY).

    • Main Results:

    • A new antibiotic, dioxamycin (1), was successfully isolated and purified.
    • The molecular formula was determined as C38H40O15.
    • Dioxamycin demonstrated in vitro activity against Gram-positive bacteria and selected tumor cell lines.
    • The structure revealed dioxamycin to be a benz[a]anthraquinone derivative, related to capoamycin.

    Conclusions:

    • Dioxamycin is a newly identified benz[a]anthraquinone antibiotic with potential therapeutic applications.
    • The structural and activity data provide a foundation for further investigation and development of dioxamycin.
    • This discovery highlights the continued importance of exploring microbial natural products for novel drug candidates.